Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-11

Clinical Trial Update: Duloxetine Combined With Intra-articular Injection of Corticosteroid and Hyaluronic Acid Reduces Pain in the Treatment of Knee Osteoarthritis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating duloxetine combined with intra-articular corticosteroid and hyaluronic acid shows reduced pain in knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroid (corticosteroid)
  • Duloxetine (DULOXETINE)
  • Hyaluronic acid (hyaluronic acid)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Osteoarthritis, Knee, Chronic Pain | Phase 4 | Status: COMPLETED